Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingevity (NGVT) Receivables (2016 - 2020)

Historic Receivables for Ingevity (NGVT) over the last 6 years, with Q4 2020 value amounting to $153.7 million.

  • Ingevity's Receivables fell 160.05% to $153.7 million in Q4 2020 from the same period last year, while for Dec 2020 it was $153.7 million, marking a year-over-year decrease of 160.05%. This contributed to the annual value of $153.7 million for FY2020, which is 160.05% down from last year.
  • Per Ingevity's latest filing, its Receivables stood at $153.7 million for Q4 2020, which was down 160.05% from $156.2 million recorded in Q4 2019.
  • In the past 5 years, Ingevity's Receivables ranged from a high of $182.9 million in Q2 2019 and a low of $95.4 million during Q4 2016
  • Its 5-year average for Receivables is $131.2 million, with a median of $124.0 million in 2018.
  • As far as peak fluctuations go, Ingevity's Receivables plummeted by 308.48% in 2017, and later surged by 3545.53% in 2018.
  • Quarter analysis of 5 years shows Ingevity's Receivables stood at $95.4 million in 2016, then increased by 9.43% to $104.4 million in 2017, then increased by 18.77% to $124.0 million in 2018, then rose by 25.97% to $156.2 million in 2019, then decreased by 1.6% to $153.7 million in 2020.
  • Its Receivables stands at $153.7 million for Q4 2020, versus $156.2 million for Q4 2019 and $174.1 million for Q3 2019.